Glycophorin A expression in malignant hematopoiesis

Area of Science:

• Hematology
• Immunology
• Oncology

Background:

• Glycophorin A (GpA) is a surface protein found on red blood cells and their precursors.
• Previous studies suggested GpA expression on a significant proportion of acute leukemia cells.
• The role and expression patterns of GpA in hematopoietic malignancies require further clarification.

Purpose of the Study:

• To assess the reactivity of a novel monoclonal anti-human glycophorin A antibody (VIE-G4) with malignant cells from patients with hematopoietic malignancies.
• To investigate potential discrepancies in GpA expression between this study and previous findings.
• To explore the implications of observed GpA expression patterns for leukemia cell differentiation.

Main Methods:

• Testing of 229 patient samples with hematopoietic malignancies using the monoclonal antibody VIE-G4.
• Classification of 123 cases as acute leukemias (myeloid, lymphoid, erythroid, undifferentiated).
• Characterization of VIE-G4 antibody reactivity with K-562 cells and erythroid precursor cells.

Main Results:

• The monoclonal antibody VIE-G4 selectively reacts with complete glycosylated glycophorin A.
• Apart from two acute erythroid leukemia cases, VIE-G4 showed no reactivity with malignant cells in 229 tested hematopoietic malignancies.
• This contrasts with prior reports suggesting broader GpA expression in acute leukemias.

Conclusions:

• The limited reactivity of VIE-G4 suggests that many acute leukemias may not express complete glycosylated GpA.
• The findings indicate a potential discrepancy due to the antibody's specificity for fully glycosylated GpA.
• Poorly differentiated leukemia cells might express incompletely glycosylated GpA, explaining the observed differences.